期刊文献+

狼疮性肾炎患儿血清总IgE水平变化及临床意义 被引量:1

Clinical significance of changes in total serum IgE level in children with lupus nephritis
在线阅读 下载PDF
导出
摘要 目的探讨血清总IgE变化水平在儿童狼疮性肾炎病情活动中的临床意义。方法采用ELISA法测定狼疮性肾炎患儿和对照组患儿血清中总IgE含量,并检测其24小时尿蛋白定量、尿蛋白/肌酐、血肌酐、血尿素氮,计算肾小球滤过率。结果狼疮性肾炎组患儿血清总IgE水平较对照组显著升高,差异有高度统计学意义(t=3.889,P<0.01),高IgE亚组患儿公斤体重24小时尿蛋白定量和尿蛋白/尿肌酐水平均明显高于低IgE亚组,差异有统计学意义(t值分别为2.233、2.125,均P<0.05),但两亚组的血肌酐、血尿素氮和肾小球滤过率均无显著统计学差异(t值分别为0.808、1.194、0.522,均P>0.05)。结论血清IgE对判断狼疮性肾炎病情活动有意义,调节IgE表达可能有助于改善狼疮性肾炎患儿的病情。 Objective To investigate the clinical significance of total serum IgE level change in children with lupus nephritis( LN).Methods The total IgE levels in serum of children with LN and that in control group were measured by enzyme-linked immunosorbent assay( ELISA). The 24-hour urinary protein,urine protein/creatinine,serum creatinine and blood urea nitrogen were detected,and glomerular filtration rate was then estimated. Results The level of total serum IgE in LN group was significantly higher than that in the control group( t = 3. 889,P〈0. 01). The urine protein/creatinine and 24-hour urinary protein levels were significantly lower in children with low IgE level than those with high IgE level( t value was 2. 125 and 2. 233,respectively,both P〈0. 05). But there was no significant difference in serum creatinine,blood urea nitrogen and glomerular filtration rate between two subgroups( t value was 0. 808,1. 194 and 0. 522,respectively,all P〉0. 05). Conclusion Serum IgE level may be meaningful to predicting disease activity of LN. Furthermore,regulation of IgE expression may relieve the condition of LN in the future.
作者 余玲 毛建华
出处 《中国妇幼健康研究》 2017年第10期1208-1210,共3页 Chinese Journal of Woman and Child Health Research
关键词 狼疮性肾炎 免疫球蛋白 儿童 酶联免疫吸附法 lupus nephritis (LN) immunoglobulin E (IgE) children enzyme-linked immunosorbent assay (ELISA)
  • 相关文献

二级参考文献49

  • 1刘志红,黎磊石.狼疮肾炎的治疗[J].中国实用内科杂志:临床前沿版,2006,26(1):86-87. 被引量:13
  • 2王禹,刘晓丹,栗霄立,王力宁,周希静.亚临床狼疮肾炎的临床病理分析及随访[J].中华肾脏病杂志,2006,22(6):370-371. 被引量:4
  • 3Austin HA,Muenz LR,Joyce KM,et al.Prognosic factors in lupus nephritis.Contribution of renal histologic data.Am J Med,1983,75:382-391.
  • 4Esdaile JM JL,MacKenzie T,Kashgarian M,et al.The benefit of early treatment with immunosuppressive agents in lupus nephritis.J Rheumatol,1994,21:2046-2051.
  • 5Houssiau FA VC,D'Cruz D,Sebastiani GD,et al.Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis:lessons from long-term followup of patients in the EuroLupus Nephritis Trial.Arthritis Rheum,2004,50:3934-3940.
  • 6Sauter M,Anders HJ.Lupus nephritis.Minerva Med,2007,98:749-758.
  • 7Flanc RS,Roberts MA,Strippoli GF,et al.Treatment of diffuse proliferative lupus nephritis:a meta-analysis of randomized controlled trials.Am J Kidney Dis,2004,43:197-208.
  • 8Grootscholten CLG,Hagen EC,van den Wall Bake AW,et al.Dutch working party on systemic lupus erythematosus.Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis.A randomized controlled trial.Kidney Iht,2006,70:732-742.
  • 9Bertsias G,Ioannidis JP,Boletis J,et al.EULAR recommendations for the management of systemic lupus erythematosus.Report of a task force of the EULAR standing committee for international clinical studies including therapeutics.Ann Rheum Dis,2008,67:195-205.
  • 10Chan TM,Tse KC,Tang CS,et al.Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.J Am Soc Nephrol,2005,16:1076-1084.

共引文献41

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部